These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
188 related items for PubMed ID: 26547670
21. Chronicle of an outbreak foretold: meningococcal meningitis W135 in Burkina Faso. Decosas J, Koama JB. Lancet Infect Dis; 2002 Dec; 2(12):763-5. PubMed ID: 12467693 [Abstract] [Full Text] [Related]
22. [Impact of a conjugated anti meningococcal A vaccine on notification of bacterial meningitis in West Burkina Faso (2009-2012)]. Ouangraoua S, Schlumberger M, Yaro S, Ouédraogo AS, Sanou S, Drabo A, Yaméogo TM, Ouedraogo R. Bull Soc Pathol Exot; 2014 Feb; 107(1):27-30. PubMed ID: 24390976 [Abstract] [Full Text] [Related]
23. [Clonal expansion of Neisseria meningitidis W135. Epidemiological implications for the African meningitis belt]. du Châtelet IP, Alonso JM, Taha MK. Bull Soc Pathol Exot; 2002 Dec; 95(5):323-4; discussion 324-5. PubMed ID: 12696368 [Abstract] [Full Text] [Related]
24. Meningococcal serogroup W135 in the African meningitis belt: epidemiology, immunity and vaccines. Mueller JE, Borrow R, Gessner BD. Expert Rev Vaccines; 2006 Jun; 5(3):319-36. PubMed ID: 16827617 [Abstract] [Full Text] [Related]
25. Bacterial meningitis in Burkina Faso: surveillance using field-based polymerase chain reaction testing. Parent du Châtelet I, Traore Y, Gessner BD, Antignac A, Naccro B, Njanpop-Lafourcade BM, Ouedraogo MS, Tiendrebeogo SR, Varon E, Taha MK. Clin Infect Dis; 2005 Jan 01; 40(1):17-25. PubMed ID: 15614687 [Abstract] [Full Text] [Related]
29. [Meningococcal meningitis epidemics in sub-Saharan Africa and the meningococcal A conjugate vaccine]. Nicolas P. Med Sante Trop; 2012 Jan 01; 22(3):246-58. PubMed ID: 23186941 [Abstract] [Full Text] [Related]
30. Positive effect of meningococcal C vaccination on serogroup replacement in Neisseria meningitidis. Pérez-Trallero E, Vicente D, Montes M, Cisterna R. Lancet; 2002 Sep 21; 360(9337):953. PubMed ID: 12354504 [No Abstract] [Full Text] [Related]
34. Health workers' perceptions and challenges in implementing meningococcal serogroup a conjugate vaccine in the routine childhood immunization schedule in Burkina Faso. Nkwenkeu SF, Jalloh MF, Walldorf JA, Zoma RL, Tarbangdo F, Fall S, Hien S, Combassere R, Ky C, Kambou L, Diallo AO, Krishnaswamy A, Aké FH, Hatcher C, Patel JC, Medah I, Novak RT, Hyde TB, Soeters HM, Mirza I. BMC Public Health; 2020 Feb 19; 20(1):254. PubMed ID: 32075630 [Abstract] [Full Text] [Related]
36. [Impact of Controlled Temperature Chain (CTC) approach on immunization coverage achieved during the preventive vaccination campaign against meningitis A using MenAfriVac in Togo in 2014]. Landoh DE, Kahn AL, Lacle A, Adjeoda K, Saka B, Yaya I, Nassoury DI, Kalao A, Makawa MS, Biey NJ, Bita A, Toke YT, Dörte P, Imboua L, Ronveaux O. Pan Afr Med J; 2017 Feb 19; 27():38. PubMed ID: 28761614 [Abstract] [Full Text] [Related]
38. [Microeconomic evaluation of a mass preventive immunisation campaign against meningococcal meningitis and yellow fever in Senegal in 1997]. da Silva A, Parent du Châtelet I, Beckr Gaye A, Dompnier JP, Seck I. Sante; 2003 Feb 19; 13(4):215-23. PubMed ID: 15047438 [Abstract] [Full Text] [Related]